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M A J O R A R T I C L E
Influence of Bacille Calmette-Gue´rin Vaccination on
Size of Tuberculin Skin Test Reaction: To What Size?
F. Tissot,1 G. Zanetti,1 P. Francioli,1 J.-P. Zellweger,3 and F. Zysset2
1Service of Infectious Diseases, 2Unit of Occupational Health, and 3Medical Outpatient Clinic, University Hospital, Lausanne, Switzerland
Background. Previous bacillus Calmette-Gue´rin (BCG) vaccination can confound the results of a tuberculin
skin test (TST). We sought to determine a cutoff diameter of TST induration beyond which the influence of BCG
vaccination was negligible in evaluating potential Mycobacterium tuberculosis infection in a population of health
care workers with a high vaccination rate and low incidence of tuberculosis.
Methods. From 1991 through 1998, all new employees at the University Hospital of Lausanne, Switzerland,
underwent a 2-step TST at entry visit. We also gathered information on demographic characteristics, along with
factors commonly associated with tuberculin positivity, including previous BCG vaccination, history of latent M.
tuberculosis infection, and predictors for M. tuberculosis infection.
Results. Among the 5117 investigated subjects, we found that influence of BCG vaccination on TST results
varied across categories of age (likelihood ratio test, 0.0001). Prior BCG vaccination had a strong influence on
skin test results of 18 mm in diameter among persons !40 years old, compared with the influence of factors
predictive of M. tuberculosis infection. Prior latent M. tuberculosis infection and travel or employment in a country
in which tuberculosis is endemic also had significant influences.
Conclusions. Interpretation of TST reactions of 18 mm among BCG-vaccinated persons !40 years of age
must be done with caution in areas with a low incidence of tuberculosis. In such a population, except for persons
who have never been vaccinated, TST reactions of 18 mm are more likely to be the result of prior vaccination
than infection and should not systematically lead to preventive treatment.
The tuberculin skin test (TST), introduced in 1910 by
Mantoux, is one of the oldest diagnostic tests used in
clinical medicine. It remains the only technique to iden-
tify latent Mycobacterium tuberculosis infection. How-
ever, the TST has various shortcomings, mainly because
several factors others than latent M. tuberculosis infec-
tion can influence its positivity. Intersubject variability
in biological response to tuberculin [1], interreader var-
iability [1], the booster effect [2–4], immune response
to nontuberculous mycobacterial antigens [3, 5, 6], and
previous vaccination with bacillus Calmette-Gue´rin
(BCG) can all be responsible for a positive TST result
[5, 7–12]. BCG vaccination is the main problem in
interpreting TST results, in particular in countries
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where the rate of vaccination is high and the prevalence
of tuberculosis is low. One must be cautious in inter-
preting TST reactions because of the potential impli-
cations associated with a positive result, such as the
need for chest radiography and 6- to 9-month preven-
tive chemotherapy, the risk of treatment hepatotoxicity,
and the anxiety generated in the patient. Whereas it is
generally assumed that a TST reaction of 15 mm in
diameter is due to M. tuberculosis infection [13–15],
positive TST reactions of !15 mm are more difficult
to interpret in countries in which the prevalence of
tuberculosis is low and the rate of prior vaccination
remains high despite discontinuation of mass immu-
nization (as in Switzerland, for example). This problem
is an everyday challenge in hospitals in which the TST
is routinely performed when new health care workers
are hired. It is therefore important to assess the influ-
ence of previous BCG vaccination on TST positivity.
In our study, we tried to determine, according to the
age of subjects, a cutoff for TST reaction size beyond
which this influence was negligible.
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PATIENTS AND METHODS
Data collection. This was a prospective cohort study involv-
ing all new health care workers hired by the University Hospital
of Lausanne, Switzerland, from January 1991 through March
1998. At the entry visit, information on new employees was
obtained, including demographic data and data pertaining to
the following characteristics (possibly related to tuberculin reac-
tivity): country of origin, occupation, history of travel to a
country with a high incidence of tuberculosis, history of em-
ployment in a hospital in a country with a high incidence of
tuberculosis, history of occupational or household exposure to
active tuberculosis, history of latent M. tuberculosis infection,
receipt of prior TSTs, and previous BCG vaccination.
Countries of origin were categorized into those with low (!24
cases per 100,000 population per year), moderate (24–99 cases
per 100,000 population per year), or high (100 cases per
100,000 population per year) incidence of tuberculosis, as re-
ported by the 1997 report of the World Health Organization.
Occupation status was determined according to whether the
employee was in contact with patients. Latent M. tuberculosis
infection was considered only for employees who demonstrated
tuberculin conversion, underwent thorough evaluation of risk
factors and chest radiography, and received preventive che-
motherapy. Vaccination records were checked for vaccination
status and number of previous TSTs received. If the record was
unavailable, information regarding immunizations was ex-
tracted from the interview. Subjects were not screened for the
presence of a BCG vaccination scar because of possible con-
fusion with smallpox vaccination scars and because BCG vac-
cination does not elicit scars in up to 25% of people [16].
Employees for whom former BCG vaccination, treatment for
latent M. tuberculosis infection, or tuberculosis exposure could
not be determined were excluded from the analysis. History
of treatment for active tuberculosis was also a criterion for
exclusion.
TSTs. Also at the entry visit, a 2-step TST by the Mantoux
method was done. Subjects were injected intradermally with
0.1 mL of tuberculin (2 U of RT 23; Berna) on the forearm.
In the absence of a white papule confirming the intradermal
injection, the test was repeated immediately on the opposite
forearm. Trained nurses of the Unit of Occupational Health
measured the transverse diameter of induration at 48–72 h after
administration and sought medical advice in cases in which the
results were doubtful. Reactions were determined by measuring
transverse diameter of induration. Induration of 10 mm in
diameter was considered a positive result.
Subjects with a negative reaction were administered a second
TST on the contralateral forearm 8–15 days after the first test.
Induration was again measured 48–72 h after administration.
Some health care workers were not retested for the following
reasons: if they had already gone through a 2-step testing with
no evidence of a booster effect, if they had never been vacci-
nated with BCG, or if they had been tested !1 year before the
current test.
Statistical analysis. We compared employees who had a
positive TST result with those who had a negative TST result
at the following induration diameter cutoff values: 10 mm, 15
mm, 18 mm, and 20 mm . We used the 2-sided Wilcoxon rank
sum test for continuous variables and the x2 test for propor-
tions. The significance level was .05 for all tests. Significant
univariate predictors of a positive test result were then can-
didates for inclusion in a logistic regression model that was
built through a forward selection process. BCG vaccination
status was always forced in the model. Each of the excluded
covariates was then tested for possible confounding. The Wald
test was used to report the significance level of the predictors
in the final model.
To investigate whether BCG vaccination had different effects
on the result of TST across different age categories, we created
an interaction term with age (categorized as !30, 30–39, and
40 years old) and BCG vaccination. The likelihood ratio test
was used to assess the significance of this interaction term. In
case of significant interaction, a separate regression model of
predictors of TST result was built for each category of age.
These models were made homogenous by including every co-
variate that was found significant in 1 of the categories of
age. Statistical analyses were done with Stata 6.0 statistical soft-
ware (Stata).
RESULTS
Study population. Of 6721 eligible new health care workers,
433 were not included because they refused the test or did not
show up for evaluation, and 1171 were excluded because of
insufficient data. Thus, the study population comprised 5117
subjects. The only meaningful difference between excluded and
included employees was in terms of origin from a country with
a low to moderate incidence of tuberculosis (75% in the ex-
cluded population vs. 91% in the included population). Among
the 5117 health care workers included in the study, 2764 (54%)
received a second TST. The characteristics of the population
are listed in table 1. Ages ranged from 14 to 63 years.
BCG vaccination status was extracted from medical records
for 4758 persons (93%) and from interview for 359 (7%), the
latter representing 9.7% of the unvaccinated group and 6.7%
of the vaccinated group.
TST results. Of 5117 health care workers, 2037 (40%) had
a TST reaction of 10 mm in diameter on the first test. In
addition, among the 2764 subjects given a second test, 400 had
positive results on retesting. These employees were represen-
tative of all age groups. Thus, 2437 health care workers overall
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Table 1. Characteristics of study population of health care workers and univariate
predictors for a positive tuberculin skin test (TST) result.
Variable
No. (%)
of subjects
(n p 5117)
Percentage of
subjects with
TST reaction
of 10 mm
(n p 2437) P
Sex
Male 1631 (32) 52 !.001
Female 3486 (68) 45
Incidence of tuberculosis in country of origina
Low 4617 (90) 44
Moderate to high 495 (10) 53 .004
Occupationb
Contact with patients 3650 (71) 47 .606
No contact 1463 (29) 49
History of travel to country with high
incidence of tuberculosis
Yes 493 (10) 57 !.001
No 4624 (90) 46
History of work in country with high
incidence of tuberculosis
Yes 114 (2) 66 !.001
No 5003 (98) 47
History of tuberculosis contactc !.001
Occupational contact only 1050 (20) 55
Household contact only 167 (3) 56
Occupational and household contact 56 (1) 54
None 3844 (76) 45
History of latent Mycobacterium
tuberculosis infection
Yes 65 (1) 71 !.001
No 5052 (99) 47
History or record of BCG vaccination
Yes 4664 (91) 51 !.001
No 453 (9) 12
Prior documented TSTs .027
0 1224 (24) 43
1–4 2705 (53) 46
5 1188 (23) 54
Age, yearsc !.001
!30 2833 (55) 41
30–39 1486 (29) 55
40 798 (16) 54
NOTE. BCG, bacille Calmette-Gue´rin; low incidence of tuberculosis, !24 cases per 100,000
population per year; moderate incidence, 24–99 cases per 100,000 population per year; high inci-
dence, 100 cases per 100,000 population per year.
a .np 5112
b .np 5113
c .np 5117
(48%) had a positive TST result. Univariate predictors of a
positive TST result were male sex, origin from a country with
moderate to high incidence of tuberculosis, travel to a country
with a moderate or high incidence of tuberculosis, work in a
hospital in a country with a moderate or high incidence of
tuberculosis, history of tuberculosis contact, history of latent
M. tuberculosis infection, prior BCG vaccination, prior TSTs,
and older age (table 1).
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Figure 1. Comparison of tuberculin skin test (TST) reactivity among
bacille Calmette-Gue´rin (BCG)–vaccinated ( ) and nonvaccinatednp 1146
( ) health care workers, by diameter of TST reaction.np 228
Table 2. Adjusted ORs for a positive tuberculin skin test (TST)
result at different cutoff points according to bacille Calmette-
Gue´rin (BCG) vaccination.
TST reaction
diameter
Age, years
!30
(n p 2833)
30–39
(n p 1486)
40
(n p 798)
10 mma 15.0b (8.5–26.3) 12.4b (6.3–24.5) 2.4b (1.4–3.9)
15 mmc 9.2b (4.1–20.9) 12.2b (3.8–39.3) 1.2 (0.7–2.2)
18 mmd 4.5b (1.4–14.3) 9.7b (1.3–71.1) 0.8 (0.4–1.6)
20 mme 3.4 (0.8–14.1) 4.9 (0.7–36.4) 1.2 (0.4–3.6)
NOTE. Data are OR (95% CI).
a Adjusted OR for tuberculosis contact, work in a country in which tuber-
culosis is endemic, age, latent Mycobacterium tuberculosis infection, and oc-
cupation involving contact with patients ( ).np 2437
b .P ! .05
c Adjusted OR for occupation involving contact with patients, tuberculosis
contact, and age ( ).np 1060
d Adjusted OR for occupation involving contact with patients, tuberculosis
contact, age, latent M. tuberculosis infection, and sex ( ). Among sub-np 350
jects !30 years old, no unvaccinated subject had a positive test result of 18
mm in diameter. Therefore, BCG vaccination is a perfect predictor and a mul-
tivariate model including it is not possible.
e Adjusted OR for travel to country in which tuberculosis is endemic, sex,
age, and latent M. tuberculosis infection ( ). Among subjects !30 yearsnp 193
old, no unvaccinated subject had a positive test result of20 mm in diameter.
Therefore, BCG vaccination is a perfect predictor and a multivariate model
including it is not possible.
There was a very clear effect of prior BCG vaccination on
TST results: 51% of vaccinated subjects had positive TST re-
sults, compared with only 12% of unvaccinated employees (ta-
ble 1). The influence of vaccination status on TST diameter
was also statistically significant at the 3 larger cutoff diameters
(15 mm, 18 mm, and 20 mm) in univariate analysis
(figure 1).
In multivariate analysis, we found that the influence of prior
BCG vaccination on TST result varied significantly across age
categories ( ) (table 2 and figure 2). Up to 40 yearsPp .0001
of age, vaccination was the strongest predictor of a positive
TST result at cutoffs of 10 mm (adjusted OR, 15.0 for em-
ployees !30 years old and 12.4 for employees 30–39 years old)
and 15 mm (adjusted OR, 9.2 and 12.2, respectively), and was
still an independent predictor at a diameter of 18 mm (adjusted
OR, 4.5 for employees !30 years old and 9.7 for employees
30–39 years old). Other significant factors were origin from a
country with a moderate to high incidence of tuberculosis, a
history of tuberculosis contact, a history of latent M. tuberculosis
infection, and a high number (5) of prior TSTs.
Among subjects 40 years old, prior vaccination was no
longer associated with a positive TST result except at a cutoff
of 10 mm in diameter (adjusted OR, 2.4). For that age category,
only a history of M. tuberculosis infection and origin from a
country with moderate to high incidence of tuberculosis were
statistically associated with a positive TST result at greater cutoff
values (figure 2).
Only 193 subjects (4%) had a TST reaction of 20 mm in
diameter. The influence of prior BCG vaccination was no longer
significant at this cutoff point, but adjusted ORs for age groups
!30 years old (adjusted OR, 3.4) and 30–39 years old (adjusted
OR, 4.9) were still high (table 2). For TST reactions of this
diameter, only latent M. tuberculosis infection, tuberculosis con-
tact, and origin from a country with a moderate to high in-
cidence of tuberculosis were statistically significant predictors
of tuberculin reactivity.
DISCUSSION
The effect of prior BCG vaccination on tuberculin reactivity
has been known for a long time [5–11]. However, some recent
studies tend to minimize this effect [15, 17–19]. In a study
involving schoolchildren in Singapore, Chee et al. [18] found
that, among those who had been vaccinated once at birth,
induration of 10 mm in diameter was the most sensitive and
specific cutoff value for predicting the development of tuber-
culosis. Induration of 16 mm in diameter was more predictive
for teenagers who had been revaccinated than for those who
had been vaccinated only once. Among contacts of patients
with tuberculosis in The Gambia, the size of the TST reaction
was related to the duration and proximity of contact but was
not influenced by the presence of a BCG scar [19]. A meta-
analysis by Wang et al. [15], including 26 studies published
from 1966 through 1999 (but only 4 studies with discrete data
for measurement of TST reactions), concluded that a positive
reaction of 15 mm in diameter was more likely to be caused
by M. tuberculosis infection than by previous BCG vaccination.
According to Centers for Disease Control and Prevention
(CDC) guidelines, BCG immunization status should not be
taken into account in the decision to treat latent M. tuberculosis
infection [14]. The guidelines also recommend that a TST re-
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Figure 2. Multivariate predictors for a positive tuberculin skin test (TST) result at different cutoff diameters according to age (only significant
predictors are shown). BCG, bacille Calmette-Gue´rin; origin 124, origin from a country with moderate to high incidence of tuberculosis (i.e., 124 cases
per 100,000 population per year); TB, tuberculosis or Mycobacterium tuberculosis. Bars, 95% CIs.
action of15 mm in diameter should be considered diagnostic
of latent M. tuberculosis infection among persons at low risk
for tuberculosis.
In our study population, we found that 2437 (48%) of the
subjects had a TST reaction of 10 mm in diameter, and 1060
(21%) had a TST reaction of 15 mm in diameter. All of the
individuals in the latter group should have received preventive
therapy according to the CDC guidelines. The usual predictors
for M. tuberculosis infection, such as origin from a country with
a moderate to high incidence of tuberculosis, a history of tu-
berculosis contact, and a history of latent M. tuberculosis in-
fection, were all significant at some point, although inconsis-
tently across categories of age and TST reaction size (figure 2).
Some of the positive reactions may indeed have been caused
by actual M. tuberculosis infection. However, considering the
rarity of documented prior M. tuberculosis infection in our
study population (found in 65 of 5117 subjects), it seems very
unlikely that such a proportion of health care workers had all
been infected. These findings raise doubts concerning latent
infection with M. tuberculosis being the cause of tuberculin
positivity in our study population. Therefore, we assume that
these results are likely to be due to factors other than M. tu-
berculosis infection—the primary factor being BCG vaccination.
As is the case for all studies of this subject, an important
limitation in our study was the frequent lack of official doc-
uments regarding BCG immunization status for employees
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coming from countries where there is a high prevalence of
tuberculosis. For those persons, we had to rely exclusively on
employees’ recall of having been vaccinated, thereby raising the
problem of misclassification of vaccination status. Because only
7% of employees did not have medical records, we think that
this was not a significant source of error. However, we must
assume that a certain number of persons who claimed never
to have been vaccinated did unknowingly receive BCG im-
munization in their childhood, thus minimizing the effect of
vaccination on TST results in our study.
Another limitation was the lack of 2-step testing for em-
ployees who had never been vaccinated. This may have accen-
tuated the difference between the vaccinated and unvaccinated
groups, because only the BCG-vaccinated group gained addi-
tional positive TST results on retesting. However, we think that
this bias minimized, rather than increased, the influence of BCG
on TST results, because misclassified BCG recipients would
have been most likely to have positive results on repeat testing,
as we suggested above.
Our study showed a significant difference in the rate of pos-
itive reactions among BCG recipients and nonrecipients, even
for reactions of 15 mm and 18 mm in diameter (figure 1).
We found that this influence of BCG vaccination varied with
age. Vaccination was a very important predictive factor for TST
reactions of 10 mm, 15 mm, and 18 mm in diameter
among employees who were !40 years old (table 2 and figure
2). Of note, although BCG vaccination was not significantly
associated with TST reactions of 20 mm in diameter, re-
spective ORs adjusted for age groups !30 years old (OR, 3.4)
and 30–39 years old (OR, 4.9) strongly suggested an influence
of vaccination on those reactions. Among subjects 40 years
old, prior vaccination seemed to have an effect on tuberculin
reactivity only when a 10-mm cutoff was used, but the small
number of subjects in this age group ( ) must be keptnp 775
in mind.
The fact that, among the 65 employees who reported having
received preventive therapy, as many as 29% had a negative
TST result (table 1) also raises doubts about the actual di-
agnosis of M. tuberculosis infection, even though tuberculin
reversion following antituberculous prophylaxis has been re-
ported [20]. It is more likely that some of the employees
simply showed evidence of postvaccinal tuberculin reactivity,
which faded with time.
Although a tuberculin reaction of 15 mm in diameter is
generally considered to be a good criterion for identifying latent
M. tuberculosis infection in vaccinated persons at low risk for
tuberculosis [13–15], our findings show that indurations of up
to 18 mm in diameter (and probably up to 20 mm in diameter
in persons !40 years old) are more likely attributable to pre-
vious BCG vaccination in areas of low tuberculosis prevalence.
Our observations are consistent with those already published
by De March-Ayuela [21] in 1990. Unlike the findings of Chee
et al. [18] and the conclusions of the meta-analysis by Wang
et al. [15], our results suggest that TST induration diameter is
not a reliable criterion for distinguishing tuberculin reactivity
caused by infection with M. tuberculosis from that caused by
remote BCG vaccination. This point is of great importance for
tuberculosis control policies among health care workers in in-
dustrialized countries where prevalence of tuberculosis is low
and the rate of prior vaccination is still high (despite discon-
tinuation of mass BCG immunization at birth). At their entry
visit, health care workers often undergo a routine TST, and the
finding of a large-sized induration is not infrequent, as evi-
denced in our study. These employees sometimes receive an-
tituberculous preventive treatment on the basis of a single pos-
itive TST result, although they show no risk factors for M.
tuberculosis infection. How many of them are treated each year
for postvaccinal tuberculin reactivity instead of M. tuberculosis
infection? Our study clearly demonstrates that positive TST
results should not systematically lead to the prescription of
antituberculous prophylaxis to vaccinated employees, whatever
the size of induration, but must result in strict individual eval-
uation of risk. Indeed, these recommendations obviously do
not apply to persons with known risk factors for M. tuberculosis
infection, such as contact with an infectious patient, for whom
a TST would not be done as a routine test but as part of a
postexposure investigation. The incidence of tuberculosis is also
an important factor in the interpretation of TST results, and
the influence of BCG vaccination on tuberculin positivity has
less importance than does M. tuberculosis infection in areas of
endemicity, which could explain the difference between the
results of the studies by Chee et al. [18] (conducted in Sin-
gapore, where the 1987–1997 tuberculosis incidence was 48–
56 cases/100,000 population per year) and Lienhardt et al. [19]
(conducted in The Gambia, where 1999 tuberculosis incidence
was 118 cases/100,000 population per year) and the results of
our study (conducted in Switzerland, where 2000 tuberculosis
incidence was 8.7 cases/100,000 population per year) [22].
The results of our study also point out the need for a better
diagnostic tool to accurately identify latent M. tuberculosis in-
fection. Although its many drawbacks are well known, the TST
has never been replaced, simply because, to date, it is the only
test approved for diagnosis of latent M. tuberculosis infection.
However, recent studies of a T cell–based enzyme-linked im-
munospot assay [23–25] showed that this ex vivo test appears
to be more accurate than the TST in identifying persons with
latent M. tuberculosis infection, and most interestingly, it is not
associated with former BCG vaccination. In the future, this
sensitive and specific test might put an end to the troublesome
interpretation of the century-old TST.
Determination of tuberculin reactivity and a booster phe-
nomenon for health care workers at their hire may be of par-
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ticular help in assessing the presence of latent M. tuberculosis
infection in the event of later contact with a documented case
of tuberculosis. This is considered one of the indications for
routine use of TST.
The present study shows that interpretation of routine TSTs
remains difficult in BCG-vaccinated persons and must be done
with caution, particularly when there is no available infor-
mation on prior tests or investigation of a booster effect. In
areas with low incidence of tuberculosis, except for persons
who have never been vaccinated, TST reactions of up to 18
mm in diameter in persons !40 years old are more likely to
be the result of prior vaccination than of infection and should
not systematically lead to preventive chemotherapy.
Of note, the influence of BCG immunization on tuberculin
reactivity varies with age and tends to be more pronounced for
young adults. This population is likely to be most at risk for
a positive TST result not related to M. tuberculosis infection
but to BCG vaccination. Thus, caution should be applied when
drawing conclusions in the absence of significant risk factors
or evidence for M. tuberculosis infection. Moreover, the lack of
specificity of TST results shows the current uncertainties sur-
rounding the diagnosis of latent M. tuberculosis infection in
such situations and underlines once again the need for a more
accurate test.
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